Home › Free Stock Grades › RDNT
RadNet, Inc. (RDNT) Stock Grade
RDNT · Healthcare
A-
Market Cap
$5.4B
P/E Ratio
—
Revenue Growth (YoY)
+11.5%
Net Margin
-0.9%
Return on Equity
—
Dividend Yield
None
About RadNet, Inc.'s fundamentals
RadNet is a $5.4 billion healthcare diagnostics company experiencing solid revenue growth of 11.5% year-over-year, though it reported a net loss in its latest annual statement with a net margin of -0.9%. Despite the accounting loss, the company generated positive free cash flow, suggesting its operations are producing cash even as expenses exceed revenues on a GAAP basis. The company does not pay a dividend, with all capital retained for reinvestment in growth and operations.